FMP

FMP

Enter

NRBO - NeuroBo Pharmaceutic...

Valuation of NeuroBo Pharmaceuticals, Inc.(NRBO), NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurode

photo-url-https://financialmodelingprep.com/image-stock/NRBO.png

NeuroBo Pharmaceuticals, Inc.

NRBO

NASDAQ

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene, an acute indication for COVID-19. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.

3.61 USD

0.01 (0.277%)

Valuation Date:

Apr 12, 2024 3:00 PM

Share Price on Valuation Date

$3.61

Stock Beta

-0.456

Shares Outstanding

4906030

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep